No Default Funding. In no event shall Landlord have any obligation to fund any portion of the TI Allowance during any period that Tenant is in Default under the Lease.
Appears in 5 contracts
Samples: Lease (Intellia Therapeutics, Inc.), Lease Agreement (Iovance Biotherapeutics, Inc.), Lease Agreement (ChemoCentryx, Inc.)
No Default Funding. In no event shall Landlord have any obligation to fund any portion of the TI Allowance or to perform any Landlord’s Work during any period that Tenant is in Default under the Lease.
Appears in 4 contracts
Samples: Lease Agreement (Kymera Therapeutics, Inc.), Lease Agreement (Constellation Pharmaceuticals Inc), Lease (Rubius Therapeutics, Inc.)
No Default Funding. In no event shall Landlord have any obligation to fund any portion of the TI Allowance or to perform any Landlord’s Work during any period that Tenant is in Default under the Lease.. Schedule 1
Appears in 2 contracts
Samples: Lease Agreement (Mirati Therapeutics, Inc.), Lease Agreement (Mirati Therapeutics, Inc.)
No Default Funding. In no event shall Landlord have any obligation to fund any portion of the TI Allowance or to perform any Landlord’s Work during any period that Tenant is in Default under the Lease.. Schedule 1 Warm Shell
Appears in 2 contracts
Samples: Lease Agreement (Twist Bioscience Corp), Lease Agreement (Twist Bioscience Corp)
No Default Funding. In no event shall Landlord have any obligation to fund any portion of the TI Allowance during any period that Tenant is in Default under the Lease.. EXHIBIT C
Appears in 1 contract
No Default Funding. In no event shall Landlord have any obligation to fund any portion of the TI Allowance during any period that Tenant is in an Event of Default exists under the Lease.
Appears in 1 contract
Samples: Lease (Fibrogen Inc)
No Default Funding. In no event shall Landlord have any obligation to fund any portion of the TI Allowance or to perform any Landlord’s Work during any period that Tenant is in Default under the Lease.. SCHEDULE 1
Appears in 1 contract
Samples: Lease (Atara Biotherapeutics, Inc.)
